Jane Halton is Chair of the Coalition for Epidemic Preparedness Innovations, the Institute for Health Metrics and Evaluation, and Ngamuru Advisory. She serves on the boards of Vet Partners, ASPI, Clayton Utz, and the Australian Film, Television and Radio School. Her previous roles include Chair of Suncorp Bank, Crown Resorts, and co-chair of the Global COVAX mechanism. A former Secretary of both the Department of Health and Department of Finance, Jane has deep expertise in public policy, finance, health, and ageing. Internationally, she has held senior roles with the World Health Organization and chaired the OECD Health Committee. She is an Honorary Professor at ANU and Adjunct Professor at the Universities of Sydney and Canberra. Jane has contributed significantly to public health, including tobacco control and communicable disease, and has received numerous honours including the Order of Australia and election to the US National Academy of Medicine.

Debby Blakey, GAICD, is the CEO of HESTA, Australia’s $97 billion superannuation fund for health and community services workers. With over 30 years’ experience in the superannuation and financial services sectors, she holds qualifications in Mathematics, Computer Science, Financial Advice, Governance, Pension Fund Design and Sustainability.
Debby’s leadership is characterised by a ‘people-first’ approach, focusing on enhancing member experiences and financial outcomes while also ensuring operational rigour and excellence. She is a strong advocate for innovation and transformation within the superannuation industry.
Debby is the President of the Australian Council of Superannuation Investors (ACSI), a Director of the International Corporate Governance Network (ICGN) and is the founding Chair of the 40:40 Vision initiative – promoting gender equality at executive and Board level in ASX300 companies.
Under Debby’s leadership, HESTA has been called the ‘corporate conscience of Australia’ for its commitment to strong governance, environmental management and gender equality.

Jayasree K. Iyer is the CEO of the Access to Medicine Foundation, where she leads its mission to drive change in global healthcare by engaging pharmaceutical companies to expand access to essential medicines in low- and middle-income countries. With expertise in addressing complex issues like drug pricing, intellectual property, and industry R&D priorities, she connects rigorous research insights with actionable solutions to improve global health. Under her leadership, the Foundation has also become a key player in engaging investors, holding the largest health-focused signatory network with over 145 investor signatories managing more than $22 trillion in assets under management. Jayasree is also invited as an independent observer to board meetings for several nonprofit organisations and serves on advisory and sustainability committees for both industry and NGOs. A recognised thought leader, she writes, speaks, and advises organisations on global health challenges. Jayasree regularly speaks at high-level forums, including the United Nations, World Health Organization, and World Economic Forum, and has been featured in leading outlets such as The Lancet, Fortune and Financial Times.